Sigma Healthcare Withdraws from Boots Sale Process
Key points
- Sigma Healthcare withdraws from Boots sale process
- Decision based on strategic and capital investment objectives
- Commitment to growth in core offshore markets remains
- Focus on Australian market and new market opportunities
Full summary
Sigma Healthcare Limited has announced the withdrawal from the sale process of The Boots Group. After preliminary discussions, the Sigma Board decided to cease interest immediately. The decision was based on the acquisition not meeting Sigma's strategic and capital investment objectives. Sigma remains committed to its international growth strategy, focusing on its core offshore markets, including recent activities in the UK with Greenlight Healthcare. The company is confident in its established growth strategy and will continue to assess opportunities that align with its long-term strategy.
Outlook
Sigma remains committed to its international growth strategy and will continue to assess opportunities in all markets that align with its strategy.
Summary generated by a large language model. Please interpret with care.